Bruce A. Buckingham, MD, and three other experts reviewed results from four new clinical trials examining the next generation of automated insulin delivery systems for type 1 diabetes patients during the Scientific Sessions. New technology holds promise for easing the lifestyle complications of type 1 diabetes by improving glycemic control, particularly overnight, Dr. Buckingham said.
ICYMI: Multiple studies demonstrate benefits of automated insulin delivery for type 1 diabetes management
